Data., page-12

rroodd - not a cure

IMO

Its good to read that all trials have been paid for or funds available are sufficient

$100m in cash since 2015 raised to date

3 years of trials , milestone payments and running costs and remunerations and cost of study drug and contributions to some of the concurrent trials etc...all budgeted for going ahead

We were told no capital raises in 2020 required - we all know the rest !!!!!!

lucky for the registry for the reverse 1 for 10 consolidation earlier